CSL Hong Kong Aleviate Human Coagulation Factor VIII 250IU/von Willebrand factor 500IU complex, Powder for injection (50 IU/mL FVIII)

Šalis: Australija

kalba: anglų

Šaltinis: Department of Health (Therapeutic Goods Administration)

Veiklioji medžiaga:

Factor VIII, Quantity: 250 IU; Von willebrand factor, Quantity: 500 IU

Prieinama:

CSL Behring Australia Pty Ltd

INN (Tarptautinis Pavadinimas):

Factor VIII,Von willebrand factor

Vaisto forma:

Injection, solution

Sudėtis:

Excipient Ingredients: water for injections

Vartojimo būdas:

Intravenous

Vienetai pakuotėje:

Not Required

Recepto tipas:

(S1) This Schedule is intentionally blank

Terapinės indikacijos:

Aleviate is indicated for: ? the treatment of bleeding episodes including surgical bleeding in patients with von Willebrand disease when desmopressin (DDAVP) treatment is ineffective or contraindicated. ? the treatment and prophylaxis of bleeding associated with factor FVIII deficiency due to haemophilia A.

Produkto santrauka:

Visual Identification: Clear, colourless solution; Container Life Time: 3 Years; Container Temperature: Store at 2 to 8 degrees Celsius

Autorizacija statusas:

Licence status A

Leidimo data:

2004-06-17